Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Sight Sciences, Inc. (SGHT)
|
Add to portfolio |
|
|
|
| Price: |
$17.02
| | Metrics |
| OS: |
48.7
|
M
| |
|
|
| Market cap: |
$828
|
M
| |
-266
|
% ROIC
|
|
Net cash:
|
$155
|
M
| |
$3.18
|
per share
|
|
EV:
|
$674
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
($65.0)
|
M
| |
|
|
| EPS |
($1.01)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 71.3 | 71.3 | 49.0 | 49.0 | 27.6 | 23.3 | 7.5 |
| Revenue growth | 45.7% | 45.7% | 77.1% | | 18.4% | 210.1% | |
| Cost of goods sold | 12.4 | 12.4 | 8.6 | 8.6 | 9.2 | 6.5 | 2.3 |
| Gross profit | 59.0 | 59.0 | 40.3 | 40.3 | 18.4 | 16.8 | 5.2 |
| Gross margin | 82.7% | 82.7% | 82.4% | 82.4% | 66.7% | 72.0% | 69.0% |
| Selling, general and administrative | 120.1 | 120.1 | 76.2 | 76.2 | 41.7 | 32.7 | 14.1 |
| Research and development | 22.9 | 22.9 | 15.6 | 15.6 | 8.9 | 8.1 | 5.4 |
| EBIT | -84.0 | -84.0 | -51.5 | -51.5 | -32.2 | -24.0 | -14.3 |
| EBIT margin | -117.7% | -117.7% | -105.2% | -105.2% | -116.5% | -103.0% | -189.9% |
| Pre-tax income | -86.2 | -86.2 | -62.8 | -62.8 | -34.6 | -25.9 | -14.3 |
| Income taxes | 0.0 | 0.0 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 |
| Tax rate | | | | | | | 0.0% |
| Net income | -86.2 | 0.0 | -63.0 | 0.0 | -34.7 | 0.0 | 0.0 |
| Net margin | -120.9% | 0.0% | -128.6% | 0.0% | -125.5% | 0.0% | 0.0% |
| |
| Diluted EPS | ($1.80) | $0.00 | ($2.36) | $0.00 | ($3.71) | $0.00 | $0.00 |
| Shares outstanding (diluted) | 47.8 | 47,849.1 | 26.7 | 26,734.1 | 9.4 | 9,387.1 | 9,222.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|